-
Journal of Cutaneous Medicine and... 2022
Topics: Fibroma; Fingers; Humans
PubMed: 33779338
DOI: 10.1177/12034754211003523 -
Archives of Disease in Childhood Aug 2023
Topics: Humans; Fibroma; Fingers
PubMed: 36882304
DOI: 10.1136/archdischild-2023-325339 -
Pediatrics International : Official... 2023
Topics: Humans; Fibroma; Skin Neoplasms
PubMed: 36932697
DOI: 10.1111/ped.15529 -
Fetal and Pediatric Pathology Dec 2019Lipofibromatosis is a benign pediatric soft tissue tumor arising preferentially in the distal extremities. Histologically, the tumor shows abundant adipose tissue...
Lipofibromatosis is a benign pediatric soft tissue tumor arising preferentially in the distal extremities. Histologically, the tumor shows abundant adipose tissue admixed with a spindle cell component, often concentrated in septal and perimysial locations. The index case is being presented to discuss the histopathological and immunohistochemical clues to differentiate it from other fibrofatty tumors of childhood. An 11-month-old male child presented with a slowly growing mass on the upper back. MRI findings were suggestive of an adipocytic tumor. Microscopy revealed a lesion composed of mature adipocytes and intervening fibrous bands with infiltration into the adjacent skeletal muscle, features of lipofibromatosis. Lipofibromatosis should be considered in the differential diagnosis of a pediatric fibrofatty tumor. Accurate diagnosis is essential for proper patient management as incomplete removal of the tumor may result in recurrence.
Topics: Adipose Tissue; Diagnosis, Differential; Extremities; Fibroma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Soft Tissue Neoplasms
PubMed: 31154875
DOI: 10.1080/15513815.2019.1619206 -
Mayo Clinic Proceedings Oct 2020
Topics: Adolescent; Fibroma; Fingers; Hand Dermatoses; Humans; Male
PubMed: 33012355
DOI: 10.1016/j.mayocp.2020.08.013 -
Journal of Clinical Rheumatology :... Jan 2018
Topics: Arthritis, Juvenile; Child; Diagnosis, Differential; Diagnostic Errors; Fibroma; Finger Joint; Humans; Male; Radiography; Ultrasonography
PubMed: 29065075
DOI: 10.1097/RHU.0000000000000547 -
Medicina Oral, Patologia Oral Y Cirugia... Jan 2015The aim of this work is to report a review of the literature concerning epidemiology, clinical and radiographic features as well as treatment of odontogenic myxofibroma... (Review)
Review
PURPOSE
The aim of this work is to report a review of the literature concerning epidemiology, clinical and radiographic features as well as treatment of odontogenic myxofibroma (MF).
METHODS
The PubMed database was searched using the following keywords: "odontogenic myxofibroma", "odontogenic fibromyxoma", "myxofibroma of the jaw" and "fibromyxoma of the jaw".
RESULTS
Fifteen articles reporting the experience with 24 patients were identified. Male/female ratio was 1:1.4 and the average age 29.5 years. The most frequent location was the mandible. In 66.7% of the cases the radiographic appearance was a multilocular radiolucency. Swelling was observed in 13 patients (92.86%), varying degrees of pain in 5 (35.71%) and paresthesia in only one patient (7.14%). Six out of 24 patients (26.09%) were treated with radical surgery and 17 out of 24 (73.91%) with a conservative approach. In two out of 21 cases (9.52%) a recurrence was reported.
CONCLUSIONS
MF is an extremely rare tumour and no agreement exist on the causes of its development. According to the present review, the choice of treatment should depend on variables such as localization, presence of a primary or of a recurrent lesion, age, general medical conditions and aesthetic needs of the patient.
Topics: Adult; Female; Fibroma; Humans; Jaw Neoplasms; Male; Odontogenic Tumors
PubMed: 25129249
DOI: 10.4317/medoral.19842 -
Indian Pediatrics Nov 2021
Topics: Fibroma; Humans; Infant; Skin Diseases; Skin Neoplasms; Toes
PubMed: 34837378
DOI: No ID Found -
Semergen Oct 2018
Topics: Femoral Neoplasms; Fibroma; Humans; Male; Young Adult
PubMed: 29571575
DOI: 10.1016/j.semerg.2018.02.005 -
Surgical Pathology Clinics Dec 2021The term giant cell-rich tumors of bone refers to a shared morphologic pattern in a group of different osseous lesions, that is, the abundance of osteoclastlike giant... (Review)
Review
The term giant cell-rich tumors of bone refers to a shared morphologic pattern in a group of different osseous lesions, that is, the abundance of osteoclastlike giant cells. Fitting with a broad spectrum of clinical presentations and biological behavior, the recent detection of characteristic molecular alterations in giant cell tumor of bone (H3-3), nonossifying fibroma (KRAS, FGFR1), giant cell granuloma of the jaws (KRAS, FGFR1, TRPV4), and aneurysmal bone cyst (USP6) have contributed significantly to the biological understanding of these morphologically related but clinically distinct lesions and their systematic classification, highlighting differences and pathogenic relationships.
Topics: Bone Cysts, Aneurysmal; Fibroma; Giant Cell Tumors; Giant Cells; Granuloma, Giant Cell; Humans
PubMed: 34742488
DOI: 10.1016/j.path.2021.06.010